Volume -
3 , - : 15-18 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Clinical Features of Breast Cancer in Elderly Women. 3 https://doi.org/10.58209/gmjm.2.1.15
URL: http://daneshafarand.org/article-1-197-en.html
URL: http://daneshafarand.org/article-1-197-en.html
Abstract: (1005 Views)
Aims: About one-third of breast cancer patients occur over 70 years old. Aging leads to the modification of a number of different drugs in the treatment of breast cancer, which provides the basis for incomplete treatment of these patients. The aim of this study was to evaluate the clinical features of breast cancer in elderly women.
Instrument & Methods: This descriptive study was conducted in 2020 by reviewing the clinical records of all women with breast cancer over the age of 70 over a ten-year period ending in 2020 with a clinical record of 183 patients. Demographic information, type of tumor pathology, clinical stage of the tumor, status of hormone receptors and tumor HER2 protein, type of surgery, type of adjuvant treatment was extracted from the files and used.
Findings: In 88 non-metastatic patients, there were 90 lymph nodes positive, of which 33 (37.5%) had no estrogen receptor and 55 (62.5%) had estrogen receptor. The most systemic treatment in patients with estrogen receptor-free tumor was chemotherapy (81.8%) and in patients with estrogen receptor tumor, chemotherapy plus hormone therapy (58.2%). there were 40 non-metastatic lymph node-negative patients, of which 9 (22.5%) had no estrogen receptor and 31 (77.5%) had estrogen receptor. The most systemic treatment received in patients without estrogen receptor was only chemotherapy (77.8%) and in patients with estrogen receptor tumor was only hormone therapy (54%).
Conclusion: The most common stage of the breast cancer in over 70 years old women is type IIB.
Instrument & Methods: This descriptive study was conducted in 2020 by reviewing the clinical records of all women with breast cancer over the age of 70 over a ten-year period ending in 2020 with a clinical record of 183 patients. Demographic information, type of tumor pathology, clinical stage of the tumor, status of hormone receptors and tumor HER2 protein, type of surgery, type of adjuvant treatment was extracted from the files and used.
Findings: In 88 non-metastatic patients, there were 90 lymph nodes positive, of which 33 (37.5%) had no estrogen receptor and 55 (62.5%) had estrogen receptor. The most systemic treatment in patients with estrogen receptor-free tumor was chemotherapy (81.8%) and in patients with estrogen receptor tumor, chemotherapy plus hormone therapy (58.2%). there were 40 non-metastatic lymph node-negative patients, of which 9 (22.5%) had no estrogen receptor and 31 (77.5%) had estrogen receptor. The most systemic treatment received in patients without estrogen receptor was only chemotherapy (77.8%) and in patients with estrogen receptor tumor was only hormone therapy (54%).
Conclusion: The most common stage of the breast cancer in over 70 years old women is type IIB.
Article Type: Descriptive & Survey |
Subject:
Biotechnology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |